SH

SUSANNA HASTINGS

HARMONY BIOSCIENCES · plymouth meeting, PA · registered since 2024
Registered · LDAActive

At a glance

Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
4
3 agencies contacted
Activity
filings by quarter
Works on

Background

Career
plymouth meeting, PA
2024 - present

Specific issues

H.R. 5547, Maintaining Investments in New Innovation (MINI) Act H.R.7174, Ensuring Pathways to Innovative Cures (EPIC) Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act H.R. 6664, Innovation in Pediatric Drugs Act H.R. 7384, Creating Hope Reauthorization Act H.R. 7383, Retaining Access and Restoring Exclusivity (RARE) Act H.R.7024, Tax Relief for American Families and Workers Act of 2024 H.R.3433 / S.2897, Give Kids a Chance Act
Pharmacy · 2024 Q4
H.R. 5547, Maintaining Investments in New Innovation (MINI) Act H.R.7174 Ensuring Pathways to Innovative Cures (EPIC) Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act H.R. 6664, Innovation in Pediatric Drugs Act H.R. 7384, Creating Hope Reauthorization Act H.R. 7383, Retaining Access and Restoring Exclusivity (RARE) Act H.R.7024 - Tax Relief for American Families and Workers Act of 2024
Pharmacy · 2024 Q3
Issues related to the development of therapies for rare diseases: drug pricing; Medicare and Medicaid; R&D tax expensing.
Medicare/Medicaid · 2024 Q2
Issues related to the development of therapies for rare diseases: drug pricing; Medicare and Medicaid; R&D tax expensing. H.R. 5547, Maintaining Investments in New Innovation (MINI) Act H.R.7174 Ensuring Pathways to Innovative Cures (EPIC) Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act H.R. 6664, Innovation in Pediatric Drugs Act H.R. 7384, Creating Hope Reauthorization Act H.R. 7383, Retaining Access and Restoring Exclusivity (RARE) Act H.R.7024 - Tax Relief for American Families and Workers Act of 2024
Pharmacy · 2024 Q2
Issues related to the development and approval of rare disease treatments
Pharmacy · 2024 Q1

Clients

2024 · 4 filings
$██,███ / qtrUnlock

Filing history

2024 Q4
HARMONY BIOSCIENCES
Q4lda.gov →
2024 Q3
HARMONY BIOSCIENCES
Q3lda.gov →
2024 Q2
HARMONY BIOSCIENCES
Q2lda.gov →
2024 Q1
HARMONY BIOSCIENCES
Q1lda.gov →
Showing recent filings · full history on lda.gov